Cargando…

Chemical parsing: Dissecting cell dependencies with a toolkit of selective BCL-2 family inhibitors

The BCL-2/BCL-X(L) inhibitor navitoclax has shown promise for the treatment of cancer but on-target toxicities have limited its utility. Recently, the generation of selective BCL-2 family inhibitors has enabled a careful dissection of BCL-2 biology, and early work indicates that these molecules have...

Descripción completa

Detalles Bibliográficos
Autor principal: Leverson, Joel D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845185/
https://www.ncbi.nlm.nih.gov/pubmed/27308564
http://dx.doi.org/10.1080/23723556.2015.1050155

Ejemplares similares